Reward drive and rash impulsivity in dysfunctional eating and hazardous drinking women
- Natalie Loxton, University of Queensland
|
Mode effect and international tobacco smoking estimates: evidence from the National Drug Strategy Household Survey
- Dr Paul Meyer, Australian Institute of Health and Welfare
|
|
Barriers for implementation of alcohol interventions; public and D&A professionals' disagreement on the optimal set of interventions to reduce alcohol related harm in rural communities
|
Is It Really Crystal Clear That Using Methamphetamine Causes People To Engage In Unsafe Sex?
- Dr Erol Digiusto, National Drug and Alcohol Research Centre, University of NSW
|
Guides to dealing with risky drinking for parents and teenagers
- Amanda J Holt, NSW Health
|
Blurred – An indicated health promotion activity, collecting images by young people on their experiences of substance use, within a youth clinical counselling service
- Mr John M Kelly, Youth Community Team, Alcohol and Drug service, Queensland Health
- Ms Emma Armitage
|
Reasons for leaving treatment: findings from the Alcohol and other Drug Treatment Services National Minimum Data Set
- Karen Blakey-Fahey, Australian Institute of Health and Welfare
- Amber Summerill, Australian Institute of Health and Welfare
|
Opioid agonist pharmacotherapy in New South Wales from 1985 to 2006: Patient characteristics and patterns and predictors of treatment retention
- Lucinda Burns, National Drug and Alcohol Research Centre, UNSW
|
An Evaluation of the AIMS Brief Intervention for Young People Who Are Using Substances
- Ms Jane Fischer, Centre for Drug and Alcohol Studies, Queensland Health
|
Stimulating Access: Attracting and retaining stimulant users in a treatment program
- Susan L Hudson, St Vincent's Hospital
|
Metacognitions among methamphetamine users in a randomised trial of motivational interviewing and cognitive behaviour therapy
- Nicole K Lee, Turning Point
|
Systematic gender differences in opioid substitution treatment: challenges and opportunities for enhanced service delivery
- Ms Belinda Lloyd, Drugs of Dependence Unit, Queensland Health
|
ACCU: The Adolescent Cannabis Check-up
- Ms Etty Matalon, National Cannabis Prevention and Information Centre
|
Post Operative Recovery of Opioid Tolerant Patients
- Ms Jayne McCarthur, Postanaesthesia Recovery, Royal Adelaide Hospital, Australia
- Ms Tara Kennedy, Postanaesthesia Recovery, Royal Adelaide Hospital, Australia
|
Injectable Opioid Treatment- Clinical experiences of the first fully supervised prescribed opioid treatment clinic in the UK
- Mr Rob van der Waal, South London and Mausdsley NHS Foundation Trust, United Kingdom
|
An evaluation of a heroin overdose prevention and education campaign
- Dr Peter G Higgs, Burnet Institute
|
Buprenorphine Injection and Risk of HIV and Hepatitis among IDUs in Nepal
- Ajit Karki, Hepa Foundation, Nepal
|
First point of contact. The evidence into practice of frontline comorbidity care for nurses and midwives
- Peter Athanasos, Discipline of Nursing, University of Adelaide
|
Coordinating Sector Development in Comorbidity:The WA approach
- Ms Melinda Spencer
- Mike Seward, WANADA
|
High rate of mortality in a large community-based cohort of inner city residents
- Jason Grebely, National Centre in HIV Epidemiology and Clinical Research, University of New South Wales
|
Statement of care: Contracts that provide positive outcomes for patients with drug and alcohol problems in hospitals
- Patricia J Green, Royal Melbourne Hospital
|
Post-traumatic stress disorder amongst homeless, substance-using adults
- Dr Katherine L Mills, National Drug and Alcohol Research Centre, University of New South Wales
|
Collaborative partnerhsips in responding to young people with co-existing mental health and substance problems
- Sophie N Morson, Child and Youth Mental Health Service
|
Ecstasy users: Vulnerability factors for depression and anxiety symptomatology
- Ms Rebecca M Scott, School of Psychology, Psychiatry and Psychological Medicine, Monash University
|
The 2007 National Drug Strategy Household Survey: sample, questionnaire and collection modes
- David Batts, Australian Institute of Health and Welfare
|
Does cannabis use increase the risk of death? Systematic review of epidemiological evidence on adverse effects of heavy cannabis use
- Bianca Calabria, National Drug and Alcohol Research Centre, University of New South Wales
|
Child maltreatment as a risk factor for psychiatric comorbidity among persons with opioid dependence and a matched control group
- Elizabeth Conroy, National Drug and Alcohol Research Centre
|
Pharmaceutical opioid injection in high and low heroin availability jurisdictions: the who & why
- Ms Barbara de Graaff, School of Psychology, University of Tasmania
|
Patterns of cannabis usage in the Australian population: Data from the Australian Longitudinal Study of Health and Relationships
- Mr Jason A Ferris, 1Australia Research Centre Sex Health and Society, La Trobe University, Melbourne, VIC, Australia
|
Towards DSM-V/ICD-11: Establishing Diagnostic Thresholds along the Alcohol Problems Continuum using Trend Analysis
- Rachel Grove, National Drug and Alcohol Research Centre, University of New South Wales, NSW, Australia
|
Alcohol Harms in 18-24 year olds: an 8 year profile
- Sharon Matthews, Turning Point Alcohol & Drug Centre
- Ms Monica Barratt
|
|
New drug trends – are monitoring systems based on theory or thin air?
|
Ambulance attendances related to pharmaceutical opioids: Trends and presenting characteristics 1998-2006
- Suzanne Nielsen, Turning Point Alcohol and Drug Centre
|
Cause-specific mortality over time in a cohort of individuals on opioid substitution treatment -New South Wales, 1985 to 2005
- Ms Deborah A Randall, National Drug and Alcohol Research Centre, UNSW
|
Measuring Quality of Life in Alcohol and Other Drug users – the need for improvement
- Dr Peter G Miller, Deakin University
|
Methodological and participant characteristics associated with retention in longitudinal studies of substance users
- Katherine L Mills, National Drug & Alcohol Research Centre
|
Who presents for treatment of post-traumatic stress disorder and alcohol problems?
- Dr Claudia Sannibale, National Drug & Alcohol Research Centre
|
Western Australian detainees and amphetamine type substances: Intimate profile study
- Miss Karen L Foster, Edith Cowan University
|
They drink less but the harms are greater: Patterns and consequences of alcohol use in Melbourne’s Vietnamese community
- Dr Stefan Gruenert, Odyssey House Victoria, Institute of Studies
|
|
On the dance floor and in the lounge room: responding to drug use trends in the same-sex attracted community
|
What women want in alcohol dependence recovery: Ways to maintain and sustain care for a special population of women in Australia
- Janice B Withnall, University of Western Sydney
|
A specialised model of residential care for older adults with challenging behaviours resulting from an alcohol related brain injury
- Dr Alice M Rota-Bartelink, Wintringham
|
Evaluating the cost-effectiveness of the Gatehouse intervention
- Mr Kiusiang Tay-Teo, The University of Melbourne and Deakin University
|
Evaluating the 2004-2009 phase of Australia’s National Drug Strategy: challenges and implementation framework
- Mr David McDonald, Siggins Miller (Associate)
- Dr Sally H Lai, Siggins Miller (Consultant)
|
Experiences of Suboxone treatment in WA, Victoria and NSW….some unintended effects of policy
- Ms Amanda Morris, The Langton Centre,NSW
- Ms Suzanne Robinson, New South Wales Users and AIDS association,NSW
|
Developing guidelines through a consensus process
- Amie R Frewen, NCPIC
- Dr Jill Molan
|
The Dynamics of Shame: Implications for the counsellor when working in residential rehab
- Rebecca M Gray, National Centre of HIV Social Research, University of New South Wales
|
Establishment of a dedicated buprenorphine/naloxone service within a comprehensive pharmacotherapy service
- Mr James C Nichol, Kullaroo Clinic, North Sydney Central Coast Health Service
- Ian M Chaussivert, North Sydney Central Coast Area Health Service
- Ms Karen M Thomas, Kullaroo Clinic, North Sydney Central Coast Health Service
- Ms Anne M Renouf, Kullaroo Clinic, North Sydney Central Coast Health Service
- Ms Julie A Carlin, Kullaroo Clinic, North Sydney Central Coast Health Service
|
REPIDU primary health care clinic: extending health care for Injecting Drug Users: a descriptive case study
- Dr Sharon Reid, 1) Drug Health Services, Sydney South West Area Health Service; 2) School of Public Health, University of Sydney
|
Why do GPs take part in opioid substitution programs?: A qualitative pilot study of the factors that shape private prescribers’ participation with the South Australian Private Opioid Substitution Program
- Jane Scarborough, Drug and Alcohol Services South Australia
|
An evidence-based approach for the AOD sector
- Jane L Shelling, Alcohol and other Drugs Council of Australia
|